Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated to version 2.10.2, replacing the estimated last update posted in version 2.10.0.SummaryDifference0.2%
- Check35 days agoChange DetectedThe study has expanded to include a second location in Los Angeles, California, with new contact details for Cedars Sinai Medical Center, while the previous single location and some staff members have been removed.SummaryDifference3%
- Check50 days agoChange DetectedThe website has been updated to include 3 additional interventions/treatments and has moved to revision v2.10.0, replacing the previous v2.9.7.SummaryDifference0.8%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check71 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.